Physician profile
Ramon Jimenez
NPI 1306838727
$3,088.06
in general payments reported to CMS, 2019-2025
11 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $112 · 2021: $296 · 2022: $362 · 2023: $55.56 · 2024: $155 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Travel and Lodging: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.94 |
| Travel and Lodging | $405.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,484.84 | 2019-2025 | |
| Medtronic, INC. | $360.68 | 2021-2022 | |
| Dilon Technologies, INC. | $330.21 | 2025 | Hemoblast Bellows |
| Sanara Medtech INC. | $154.74 | 2024 | Celleraterx |
| Tela Bio, INC. | $151.33 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien LP | $143.90 | 2019 | |
| Abbvie INC. | $121.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $112.08 | 2020 | |
| Conmed Corporation | $100.78 | 2022-2023 | Airseal |
| Advanced Accelerator Applications | $72.10 | 2019 | |
| Smith+Nephew, INC. | $56.40 | 2021-2025 | Stravix, Grafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.